PCVX:NASDAQ, Vaxcyte, Inc.

PCVX stock overview

Vaxcyte, Inc. (PCVX:NASDAQ) closed at $63.89 on November 6, 2026, up 3.18% on the day. The stock trades 29.6% below its 52-week high of $90.75 and 59.2% above its 52-week low of $40.14. Over the past year, it gained 53.4%. Vaxcyte, Inc. is part of the Health Care sector.

Key figures

Price: $63.89
Day change: +3.18%
Volume: 1,840,628
Average volume: 2,137,726
Market cap: 10B+
52-week range: $40.14 – $90.75
50-day average: $61.65
200-day average: $57.32

Price action over the past year

In 252 trading sessions since November 6, 2025, PCVX closed higher on 124 days (49%). Its best day was October 5, 2026 (+30.70%) and its worst was May 7, 2026 (-9.84%). The stock moved 10% or more in a single session 1 time. It opened at least 5% above the previous day's high 1 time.

Recent signals

Nov 6, 2026: Trading sideways between $59.97 and $65.68 over 14 days (Sideways scanner)
Nov 4, 2026: News catalyst: Investor Update (News Catalysts scanner)
Oct 5, 2026: Spiked to $90.75 on 14M+ shares (Spikes scanner)

PCVX news

About Vaxcyte, Inc.

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine.

Similar stocks

Find more stocks like PCVX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.